A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy Subjects

Inclusion Criteria

• •1. Subjects with ability to understand the trial procedures and possible adverse events, voluntary participation in the trial.
• •2. Subjects who can provide written informed consent.
• •3. Males or females aged 18-55 years (both inclusive).
• •4. Males with body weight ≥ 50 kg, or females with body weight ≥ 45 kg.
• •5. No clinically significant abnormalities in the medical history, general physical examinations, vital signs and laboratory tests.